SCHEMBL17952275

SCHEMBL17952275

Cc1cc(C)c(N2c3cc(C#N)c(C#N)cc3N(C)[C@@H]2C)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CASP1 P29466 3/20 0.33
▸ TDP1 Q9NUW8 3/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ CASP7 P55210 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ TAAR1 Q96RJ0 1/20 0.33
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HBB P68871 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17952187 0.87 KDM4E (0.34) KDM4EALDH1A1TSHRHPGDSMN1; SMN2
SCHEMBL17952180 0.87 L3MBTL1 (0.39) KDM4EALDH1A1TSHRHPGDSMN1; SMN2
SCHEMBL17952214 0.85 MEN1 (0.31) CASP1TDP1MAPTKMT2AMEN1
SCHEMBL17952317 0.85 MEN1 (0.32) CASP1TDP1MAPTKMT2AMEN1
SCHEMBL17952192 0.84 MEN1 (0.33) CASP1TDP1MAPTKMT2AMEN1
SCHEMBL17952334 0.83 — —
SCHEMBL17952114 0.83 — —
SCHEMBL17952259 0.82 MAPT (0.34) KDM4EALDH1A1CASP1TDP1ALOX15
SCHEMBL17952622 0.82 NPSR1 (0.36) KDM4EALDH1A1TSHRHPGDSMN1; SMN2
SCHEMBL17952369 0.82 CASP3 (0.36) KDM4EALDH1A1HPGDCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418569-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-17 — — US disclosed
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10418569-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP2 KDM4E 4426/4885ALDH1A1 1620/4885TSHR 4400/4885
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OSBP2 KDM4E 4426/4885ALDH1A1 1620/4885TSHR 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback